Literature DB >> 35151885

The current state of knowledge of the immune ecosystem in alopecia areata.

Samuel J Connell1, Ali Jabbari2.   

Abstract

Alopecia areata (AA) is an autoimmune disease that affects approximately 2% of the general population. Patients with AA most commonly present with one or more patches of hair loss on the scalp in defined circular areas. A fraction of patients progress to more severe forms of the disease, in some cases with involvement of all body surfaces. The healthy anagen stage hair follicle is considered an immune privileged site, described as an environment that suppresses inflammatory immune responses. However, in AA, this immune privileged state collapses and marks the hair follicle as a target for the immune system, resulting in peri- and intrafollicular infiltration by lymphocytes. The complexity of the inflammatory ecosystem of the immune response to the hair follicle, and the relationships between the cellular and soluble participants, in AA remains incompletely understood. Many studies have demonstrated the presence of various immune cells around diseased hair follicles; however, often little is known about their respective contributions to AA pathogenesis. Furthering our understanding of the mechanisms of disease in AA is essential for the novel identification of targeted therapeutics that are efficacious and have few unintended effects.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alopecia areata; Autoimmunity; Hair follicle; Immune privilege; Lymphocytes; T cells

Mesh:

Year:  2022        PMID: 35151885      PMCID: PMC9018517          DOI: 10.1016/j.autrev.2022.103061

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   17.390


  155 in total

1.  Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye.

Authors:  P B MEDAWAR
Journal:  Br J Exp Pathol       Date:  1948-02

2.  JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.

Authors:  Claire Harrison; Jean-Jacques Kiladjian; Haifa Kathrin Al-Ali; Heinz Gisslinger; Roger Waltzman; Viktoriya Stalbovskaya; Mari McQuitty; Deborah S Hunter; Richard Levy; Laurent Knoops; Francisco Cervantes; Alessandro M Vannucchi; Tiziano Barbui; Giovanni Barosi
Journal:  N Engl J Med       Date:  2012-03-01       Impact factor: 91.245

3.  IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans.

Authors:  Luana S Ortolan; Sa Rang Kim; Sydney Crotts; Lucy Y Liu; Brittany G Craiglow; Carlos Wambier; Renato S Paschoal; Brett A King; Ali Jabbari
Journal:  J Allergy Clin Immunol       Date:  2019-08-27       Impact factor: 10.793

4.  A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis.

Authors:  Rajshekhar Alli; Phuong Nguyen; Kelli Boyd; John P Sundberg; Terrence L Geiger
Journal:  J Immunol       Date:  2011-11-23       Impact factor: 5.422

5.  Alopecia Areata Is Associated with Atopic Diathesis: Results from a Population-Based Study of 51,561 Patients.

Authors:  Khalaf Kridin; Yael Renert-Yuval; Emma Guttman-Yassky; Arnon D Cohen
Journal:  J Allergy Clin Immunol Pract       Date:  2020-02-06

6.  The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population.

Authors:  Göknur Kalkan; Nevin Karakus; Yalçın Baş; Zennure Takçı; Pınar Ozuğuz; Omer Ateş; Serbulent Yigit
Journal:  Gene       Date:  2013-07-04       Impact factor: 3.688

7.  Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack.

Authors:  Taisuke Ito; Natsuho Ito; Matthias Saatoff; Hideo Hashizume; Hidekazu Fukamizu; Brian J Nickoloff; Masahiro Takigawa; Ralf Paus
Journal:  J Invest Dermatol       Date:  2007-12-27       Impact factor: 8.551

8.  An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis.

Authors:  A Jabbari; F Sansaricq; J Cerise; J C Chen; A Bitterman; G Ulerio; J Borbon; R Clynes; A M Christiano; J Mackay-Wiggan
Journal:  J Invest Dermatol       Date:  2018-02-13       Impact factor: 8.551

9.  Alopecia areata in aging C3H/HeJ mice.

Authors:  J P Sundberg; W R Cordy; L E King
Journal:  J Invest Dermatol       Date:  1994-06       Impact factor: 8.551

10.  Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia areata.

Authors:  G Conteduca; A Rossi; F Megiorni; A Parodi; F Ferrera; S Tardito; F Battaglia; F Kalli; S Negrini; A Pizzuti; E Rizza; F Indiveri; D Fenoglio; G Filaci
Journal:  Clin Exp Med       Date:  2012-11-30       Impact factor: 3.984

View more
  1 in total

Review 1.  An overview of JAK/STAT pathways and JAK inhibition in alopecia areata.

Authors:  Maddison Lensing; Ali Jabbari
Journal:  Front Immunol       Date:  2022-08-30       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.